Please assess the completion status of the following clinical trial:

Trial Title: MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is at least 18 years of age~* Patient is Human Immunodeficiency Virus (HIV) positive~* Patient has documented Human Immunodeficiency Virus (HIV) RiboNucleic Acid (RNA) \<50 copies/milliliter (mL) for at least 3 months while on a KALETRA based regimen~* Patient has been on a KALETRA based regimen for at least 3 months without a change in background antiretroviral therapy~* Patient has no documentation of HIV RNA \>50 copies/mL for at least 3 months while on the KALETRA based regimen~Exclusion Criteria:~* Patient is or plans to become pregnant, or nursing a child~* Patient plans to donate eggs or impregnate/donate sperm~* Patient is receiving Stavudine (d4T) as a component of the background antiretroviral therapy~* Patient is currently receiving a second protease inhibitor in addition to KALETRA~* Patient is currently receiving, or has received in the past twelve weeks, treatment for the management of elevated lipids~* Patient has used another experimental HIV-integrase inhibitor~* Patient has a current (active) diagnosis of acute hepatitis due to any cause~* Patient has used systemic immunosuppressive therapy within one month prior to treatment in this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Arm 1: MK0518 (raltegravir) + placebo to KALETRA™ (lopinavir (+) ritonavir )
- 2 (Type: ACTIVE_COMPARATOR): Arm 2: KALETRA™ (lopinavir (+) ritonavir) + placebo to MK0518 (raltegravir)

Based on this trial design, predict the completion outcome and termination type (if applicable).